Inquire About a Product| Product: | Arecoline-d5 hydrobromide salt | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | D4345 | ||||||||
| CAS Number: | 131448-18-5 | ||||||||
| Synonyms: |
(1,2,5,6-Tetrahydro-1-(methyl-D3)-3-pyridine-2,6-D2-carboxylic Acid, Methyl Ester Hydrobromide); 1-Methyl-1,2,5,6-tetrahydro-pyridine-3-carboxylic Acid-d5 Methyl Ester; Arecaidine-d5 Methyl Ester; Arecolin-d5; Methylarecaidine-d5 |
||||||||
| Pricing: |
|
||||||||
| Formula: | C8H9D5BrNO2 | ||||||||
| Enrichment: | 98%D | ||||||||
| Molecular Weight: | 241.14 | ||||||||
| Structure: |
|
||||||||
| Category: | Labeled Reference Standards | ||||||||
| Literature References: |
Saikia JR, Schneeweiss FH, Sharan RN. "Arecoline-induced changes of poly-ADP-ribosylation of cellular proteins and its influence on chromatin organization.". Cancer Letters. 139 (1): 59–65, (1999).; Christie JE, Shering A, Ferguson J. "Physostigmine and arecoline: effects of intravenous infusions in Alzheimer’s presenile dementia". British Journal of Psychiatry 138 (1): 46–50 (1981); Yusuf H, Yong SL. "Oral submucous fibrosis in a 12-year-old Bangladeshi boy: a case report and review of literature". International journal of paediatric dentistry / the British Paedodontic Society [and] the International Association of Dentistry for Children 12 (4): 271–6 (2002). |
||||||||
| MSDS: | |||||||||
| Applications: | A labeled agonist of the muscarinic acetylcholine receptors. Usually causes smooth muscle contraction. Has been shown to improve learning and memory. Possible treatment for Alzheimer's and other forms of dementia. |